NM_007217.4(PDCD10):c.193A>C (p.Lys65Gln) AND Inborn genetic diseases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 11, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003360724.2

Allele description [Variation Report for NM_007217.4(PDCD10):c.193A>C (p.Lys65Gln)]

NM_007217.4(PDCD10):c.193A>C (p.Lys65Gln)

Gene:

PDCD10:programmed cell death 10 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

3q26.1

Genomic location:

Preferred name:

NM_007217.4(PDCD10):c.193A>C (p.Lys65Gln)

HGVS:

NC_000003.12:g.167697084T>G
NG_008158.1:g.42780A>C
NM_007217.4:c.193A>CMANE SELECT
NM_145859.2:c.193A>C
NM_145860.2:c.193A>C
NP_009148.2:p.Lys65Gln
NP_665858.1:p.Lys65Gln
NP_665859.1:p.Lys65Gln
LRG_651t1:c.193A>C
LRG_651:g.42780A>C
LRG_651p1:p.Lys65Gln
NC_000003.11:g.167414872T>G
NM_145860.1:c.193A>C

Protein change:

K65Q

Molecular consequence:

NM_007217.4:c.193A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_145859.2:c.193A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_145860.2:c.193A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004053850	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Aug 11, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004053850

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Aug 11, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV004053850.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.K65Q variant (also known as c.193A>C), located in coding exon 3 of the PDCD10 gene, results from an A to C substitution at nucleotide position 193. The lysine at codon 65 is replaced by glutamine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 1, 2024

ClinVar

Relating variation to medicine